{"id":"https://openalex.org/W2157356802","doi":null,"title":"The effect of new anthracycline derivatives on the induction of apoptotic processes in human neoplastic cells.","display_name":"The effect of new anthracycline derivatives on the induction of apoptotic processes in human neoplastic cells.","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W2157356802","mag":"2157356802","pmid":"https://pubmed.ncbi.nlm.nih.gov/15253137"},"language":"en","primary_location":{"id":"pmid:15253137","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15253137","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia histochemica et cytobiologica","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029978947","display_name":"Beata Gruber","orcid":"https://orcid.org/0000-0003-2819-8576","observed_orcids":["https://orcid.org/0000-0003-2819-8576"]},"institutions":[{"id":"https://openalex.org/I4210101740","display_name":"Narodowy Instytut Zdrowia Publicznego PZH \u2013 Pa\u0144stwowy Instytut Badawczy","ror":"https://ror.org/015qjap30","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210101740"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Beata M Gruber","raw_affiliation_strings":["Department of Biochemistry and Biopharmaceuticals, National Institute of Public Health, Warsaw, Poland. b-gruber@il.waw.pl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Biopharmaceuticals, National Institute of Public Health, Warsaw, Poland. b-gruber@il.waw.pl","institution_ids":["https://openalex.org/I4210101740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000343896","display_name":"El\u017cbieta Anuszewska","orcid":"https://orcid.org/0000-0001-6740-4905","observed_orcids":["https://orcid.org/0000-0001-6740-4905"]},"institutions":[{"id":"https://openalex.org/I4210166577","display_name":"Narodowy Instytut Lek\u00f3w","ror":"https://ror.org/05m2pwn60","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210166577"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Elzbieta L Anuszewska","raw_affiliation_strings":["National Medicines Institute, Warsaw"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Medicines Institute, Warsaw","institution_ids":["https://openalex.org/I4210166577"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062959791","display_name":"Waldemar Priebe","orcid":"https://orcid.org/0000-0003-4522-4772","observed_orcids":["https://orcid.org/0000-0003-4522-4772","https://orcid.org/0000-0003-3969-0144"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Waldemar Priebe","raw_affiliation_strings":["Experimental Therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0962,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.34674685,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"42","issue":"2","first_page":"127","last_page":"30"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.8955000042915344,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.8955000042915344,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.05220000073313713,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.03920000046491623,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anthracycline-derivatives","display_name":"anthracycline derivatives","score":0.9679999947547913},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.843999981880188},{"id":"https://openalex.org/keywords/apoptosis-induction","display_name":"apoptosis induction","score":0.8259999752044678},{"id":"https://openalex.org/keywords/melanoma-cells","display_name":"melanoma cells","score":0.8169999718666077},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7179999947547913},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5070000290870667}],"concepts":[{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.8852722644805908},{"id":"https://openalex.org/C2775934118","wikidata":"https://www.wikidata.org/wiki/Q424169","display_name":"Propidium iodide","level":4,"score":0.7725163698196411},{"id":"https://openalex.org/C88634738","wikidata":"https://www.wikidata.org/wiki/Q24769543","display_name":"Annexin","level":3,"score":0.687972366809845},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6862983703613281},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.6457613110542297},{"id":"https://openalex.org/C2225953","wikidata":"https://www.wikidata.org/wiki/Q1661899","display_name":"Inducer","level":3,"score":0.5987141132354736},{"id":"https://openalex.org/C196795494","wikidata":"https://www.wikidata.org/wiki/Q1624817","display_name":"TUNEL assay","level":3,"score":0.5074114203453064},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48414215445518494},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.46325597167015076},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4200507402420044},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4199789762496948},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39571166038513184},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.39000678062438965},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3353997468948364},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.33131641149520874},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2545214295387268},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.14945095777511597},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1128392219543457},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.057454913854599},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018943","descriptor_name":"Anthracyclines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15253137","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15253137","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Folia histochemica et cytobiologica","raw_type":"Journal Article"},{"id":"mag:2157356802","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15253137","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W172469862","https://openalex.org/W1538846621","https://openalex.org/W1821945515","https://openalex.org/W2010183849","https://openalex.org/W2039149747","https://openalex.org/W2070038334","https://openalex.org/W2082943886","https://openalex.org/W2090920178","https://openalex.org/W2093612767","https://openalex.org/W2160664732","https://openalex.org/W2187765434","https://openalex.org/W2428248361"],"related_works":["https://openalex.org/W2093612767","https://openalex.org/W2062921857","https://openalex.org/W191705085","https://openalex.org/W2397135499","https://openalex.org/W2253380117","https://openalex.org/W2023924866","https://openalex.org/W1564451343","https://openalex.org/W2036754777","https://openalex.org/W2742041002","https://openalex.org/W1968468453"],"abstract_inverted_index":{"This":[0],"study":[1],"was":[2,45,94,144,152],"an":[3],"attempt":[4],"to":[5,30,51,70,154,173],"determine":[6],"the":[7,27,32,38,48,97,174],"effect":[8,40,143,176],"of":[9,26,34,41,58,67,99,120,126,134,136,159,177],"a":[10,55,156,169],"selected":[11],"anthracycline":[12,42,178],"derivative,":[13],"WP903,":[14,49],"on":[15,23],"apoptotic":[16,59,142,160],"processes":[17,60],"in":[18,61,118,124,132,146],"human":[19,63],"melanoma":[20,64],"cells":[21,65,75,122],"depending":[22],"intracellular":[24],"concentrations":[25],"compound,":[28],"and":[29,72,84,90,102,106,123],"evaluate":[31],"significance":[33],"apoptosis":[35,117,166],"induction":[36],"for":[37,78],"cytotoxic":[39,175],"antibiotics.":[43,179],"It":[44],"found":[46,153],"that":[47,165],"contrary":[50],"ADR":[52,82,151],"(adriamycin)":[53],"is":[54,167],"strong":[56],"inducer":[57,158],"ME18":[62,121,147],"regardless":[66],"their":[68],"susceptibility":[69],"adriamycin":[71],"WP903.":[73],"The":[74,162],"were":[76],"treated":[77],"24":[79],"h":[80],"with":[81,96,107],"(1":[83],"5":[85],"microg/ml)":[86],"or":[87],"WP903":[88,110],"(0.2":[89],"2":[91,130],"microg/ml).":[92],"Apoptosis":[93],"detected":[95],"use":[98],"annexin":[100],"V-FITC":[101],"PI":[103],"(propidium":[104],"iodide)":[105],"TUNEL":[108],"assay.":[109],"used":[111],"at":[112,129],"0.2":[113],"microg/ml":[114,131],"induced":[115],"early":[116],"23%":[119],"60%":[125],"ME18/R":[127],"cells;":[128],"70%":[133],"each":[135],"cell":[137],"line":[138],"tested.":[139],"Significant":[140],"late":[141],"observed":[145],"cells.":[148],"In":[149],"contrast,":[150],"be":[155],"weak":[157],"events.":[161],"results":[163],"suggest":[164],"not":[168],"mechanism":[170],"directly":[171],"related":[172]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}